Literature DB >> 11276374

Lexipafant in severe acute pancreatitis: the final word?

C D Ulrich1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276374     DOI: 10.1007/s11894-001-0001-z

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


× No keyword cloud information.
  18 in total

Review 1.  Early events in acute pancreatitis.

Authors:  M L Steer
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  1999-07

Review 2.  Medical management of acute pancreatitis: strategies, reality, and potential.

Authors: 
Journal:  Curr Gastroenterol Rep       Date:  2000-04

Review 3.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

Review 4.  Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.

Authors:  L D Curtis
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

Review 5.  Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis.

Authors:  C D Johnson
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

6.  Prevalence and predictors of severe acute pancreatitis in patients with acquired immune deficiency syndrome (AIDS).

Authors:  A P Manocha; M Sossenheimer; S P Martin; K E Sherman; T Venkatesan; D C Whitcomb; C D Ulrich
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

7.  Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis.

Authors:  M Hirota; F Nozawa; A Okabe; M Shibata; T Beppu; S Shimada; H Egami; Y Yamaguchi; S Ikei; T Okajima; K Okamoto; M Ogawa
Journal:  Pancreas       Date:  2000-08       Impact factor: 3.327

8.  Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.

Authors:  C D Johnson; A N Kingsnorth; C W Imrie; M J McMahon; J P Neoptolemos; C McKay; S K Toh; P Skaife; P C Leeder; P Wilson; M Larvin; L D Curtis
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

9.  Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats.

Authors:  J A Rivera; J Werner; A L Warshaw; K B Lewandrowski; D W Rattner; C Fernández del Castillo
Journal:  Int J Pancreatol       Date:  1998-04

10.  Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis.

Authors:  A N Kingsnorth; S W Galloway; L J Formela
Journal:  Br J Surg       Date:  1995-10       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.